Significance of plasma B-type natriuretic peptide in hemodialysis patients: Blood sample timing and comorbidity burden

ASAIO Journal

Volumn 53, Issue 5, 2007, Pages 587-591

  Biasioli, Stefano ^a,c   Zamperetti, Monica ^a   Borin, Donata ^a   Guidi, Giancesare ^b   De Fanti, Emanuela ^a   Schiavon, Renzo ^a  

^a Legnago General Hospital   (Italy)

^b UNIVERSITY OF VERONA   (Italy)

^c Legnago Hospital   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD; DIALYSIS; DISEASES; ECHOCARDIOGRAPHY; HEMODIALYZERS; PATIENT MONITORING;

CARDIAC SYSTOLIC FUNCTION; HEMODIALYSIS PATIENTS; MORTALITY RATE;

PEPTIDES;

BRAIN NATRIURETIC PEPTIDE;

ADULT; ARTICLE; BLOOD SAMPLING; CHARLSON COMORBIDITY INDEX; CLINICAL ARTICLE; COMORBIDITY; ECHOCARDIOGRAPHY; FEMALE; HEART LEFT VENTRICLE EJECTION FRACTION; HEMODIALYSIS; HUMAN; KIDNEY FAILURE; MALE; MORTALITY; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; PROTEIN BLOOD LEVEL;

ADULT; AGED; COMORBIDITY; ECHOCARDIOGRAPHY; ELECTRIC IMPEDANCE; FEMALE; FOLLOW-UP STUDIES; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; RENAL DIALYSIS; TIME FACTORS; TREATMENT OUTCOME;

EID: 34648841060     PISSN: 10582916     EISSN: None     Source Type: Journal    
DOI: 10.1097/MAT.0b013e31814a57c3     Document Type: Article

References (23)

1. Suresh M, Farrington K: Natriuretic peptides and dialysis patient. Semin Dial 18: 409-419, 2005.
2. Zoccali C, Mallamaci F, Benedetto FA, et al: Cardiac natriuretic peptides are related to left ventricular mass and function and predict mortality in dialysis patients. J Am Soc Nephrol 12: 1508-1515, 2001.
3. Goto T, Takase H, Toriyama T, et al: Increased circulating levels of natriuretic peptides predict future events in patients with chronic hemodialysis. Nephron 92: 610-615, 2002.
4. Racek J, Kraiova H, Trefil L, Rajdl D, Eiselt J: Brain natriuretic peptide and N-terminal proBNP in chronic hemodialysis patients. Nephron Clin Pract 103: 162-172, 2006.
5. Lee SW, Song JH, Kim GA, Lim HJ, Kim M: Plasma BNP concentration on assessment of hydratation status in hemodialysis patient. Am J Kidney Dis 41: 1257-1266, 2003.
6. Fagugli RM, Palumbo B, Ricciardi D, et al: Association between BNP and extracellular water in hemodialysis patients. Nephron Clin Prac 95: 60-66, 2003.
7. Corboy JC, Walker RJ, Simmonds MB, Wilkins GT, Richards AM, Espiner ES: Plasma natriuretic peptides and cardiac volume during acute changes in intravascular volume in HD patients. Clin Sci 87: 679-684, 1994.
8. Nishikimi T, Futoo Y, Tamano K, et al: Plasma brain natriuretic peptide levels in chronic hemodialysis patients: influence of coronary artery disease. Am J Kidney Dis 37: 1201-1208, 2001.
9. Safley DM, Awad A, Sullivan RA, et al: Changes in B-type natriuretic peptide levels in hemodialysis and the effect of depressed left ventricular function. Adv Chronic Kidney Dis 12: 117-124, 2005.
10. Hall WH, Ramachandran R, Narayan S, Jani AB, Vijayakumar S: An electronic application for rapidly calculating Charlson comorbidity score. BMC Cancer 4: 94-101, 2004.
11. Cataliotti A, Malatino LS, Jougasaki M, et al: Circulating natriuretic peptide concentrations in patients with ESRD: role of BNP as a biomarker for ventricular remodeling. Mayo Clin Proc 76: 1111-1119, 2001.
12. McCullogh PA, Duc P, Omland T, et al: B-type natriuretic peptide and renal function in the diagnosis of heart failure: an analysis from the Breathing Not Properly Multinational Study. Am J Kidney Dis 41: 571-579, 2003.
13. De Lemos JA, McGuire DK, Drazner MH: B-type natriuretic peptide in cardiovascular disease. Lancet 362: 316-322, 2003.
14. Ishikura F, Ando Y, Park YD, et al: Changes of plasma atrial and brain natriuretic peptide levels during hemodialysis. Ren Fail 18: 261-270, 1996.
15. Clerico A, Caprioli R, Del Ry S, Gianessi D: Clinical relevance of BNP in patients on renal failure on chronic hemodialysis. J Endocrinol Invest 21: 112-119, 2001.
16. Naganuma T, Sugimura K, Wada S, et al: The prognostic role of BNP in HD patients. Am J Nephrol 22: 437-444, 2002.
17. Takahashi M, Nagake Y, Ichikawa H, et al: Plasma concentrations of natriuretic peptides in patients on hemodialysis. Res Commun Mol Pathol Pharmacol 92: 19-30, 1996.
18. Akiba T, Tachibana K, Togashi K, Hiroi M, Marumo F: Plasma BNP in chronic renal failure. Clin Nephrol 44: S61-64, 1995.
19. Anand IS, Fisher LD, Chiang YT: Plasma BNP concentration predicts survival in patients with heart failure. Circulation 107: 1278-1281, 2003.
20. Redfield MM, Rodeheffer RJ, Jacobsen SJ, Mahoney DW, Bailey KR, Burnett JC: Plasma BNP to detect preclinical ventricular systolic or diastolic dysfunction, a community-based study. Circulation 109: 3176-3181, 2004.
21. Heidenreich PA, Gubens MA, Fonarow GC, Konstam MA, Stevenson LW, Shekelle PG: Cost-effectiveness of screening with B-type natriuretic-peptide to identify patients with reduced left ventricular ejection fraction. J Am Coll Cardiol 43: 1019-1026, 2004.
22. Colucci WS, Chen HH: Brain and atrial natriuretic peptides in left ventricular dysfunction. Up To Date 13 3: 1-22, 2006.
23. Kistorp C, Raymond I, Pedersen F, Gustafsson F, Faber J, Hildebrandt P: N-terminal pro-brain natriuretic peptide, C-reactive protein, and urinary albumin levels as predictors of mortality and cardiovascular events in older adults. JAMA 293: 1609-1616, 2005.